EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Cholinergic System Changes in Dopa‐Unresponsive Freezing of Gait in Parkinson's Disease

Kelvin L Chou, Prabesh Kanel iD, Miriam van Emde Boas, Stiven Roytman iD, Giulia Carli, Roger L Albin iD, Nicolaas I Bohnen iD

Movement Disorders · 2025

DOI: 10.1002/mds.30196 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Movement Disorders, 2025. Verfasst von Kelvin L Chou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of Michigan, Ann Arbor, Michigan, USA. Hauptthemen laut MEDLINE: Parkinson Disease, Gait Disorders, Neurologic, Levodopa, Antiparkinson Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Michael J. Fox Foundation for Parkinson's Research, NINDS NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Freezing of gait (FoG) is a debilitating mobility disturbance that becomes increasingly resistant to dopaminergic pharmacotherapies with advancing Parkinson's disease (PD). The pathophysiology underlying the response of FoG to dopaminergic treatment is poorly understood. Prior vesicular acetylcholine transporter positron emission tomography (VAChT PET) imaging studies implicate the degeneration of cholinergic pathways, including bilateral striatal and limbic archicortex deficits, as significant contributors to FoG.

Objective

We aim to investigate whether specific cholinergic system changes are associated with FoG responsiveness to levodopa treatment in PD patients.

Methods

Thirty six PD subjects (31M/5F) completed [ 18 F]‐fluoroethoxybenzovesamicol ([ 18 F]FEOBV) vesicular acetylcholine transporter positron emission tomography (VAChT PET) and underwent videotaped clinical assessments for FoG on and off levodopa.

Results

Sixteen subjects had l ‐dopa‐unresponsive FoG. Whole brain voxel‐based analyses of [ 18 F]FEOBV PET (false discovery rate‐corrected at P < 0.05 and adjusted for levodopa‐equivalent dose) showed that those with l ‐dopa‐unresponsive FoG had more severe cholinergic terminal deficits in the bilateral insula, hippocampi, fimbria, and lateral geniculate nuclei; left mid‐temporal, putamen, and posterior cingulate regions; and the right mid‐frontal region and anterior ventral nucleus of the thalamus compared to those with l ‐dopa‐responsive FoG.

Conclusion

FoG unresponsive to levodopa is associated with bilateral cholinergic terminal reductions, mostly in extra‐striatal regions involved in multisensory and cognitive integration of gait and postural control as well as spatial navigation. The lack of specific striatal involvement points to the disruption of widespread cerebral network functions underlying l ‐dopa‐unresponsive FoG in PD and may explain the treatment‐resistant nature of FoG to levodopa. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseGait Disorders, NeurologicLevodopaAntiparkinson AgentsBrainHumansMaleFemalePositron-Emission TomographyAgedMiddle AgedVesicular Acetylcholine Transport ProteinsPiperidines

Stichwörter der Autor:innen

Parkinson's diseaseacetylcholinefreezing of gaitlevodopa responsivenesspositron emission tomography (PET)

Substanzen

LevodopaAntiparkinson AgentsVesicular Acetylcholine Transport Proteinsfluoroethoxy-benzovesamicolPiperidines

Autor:innen und Institutionen

  • Department of Neurology, University of Michigan, Ann Arbor, Michigan, USA.
  • Functional Neuroimaging, Cognitive, and Mobility Laboratory, Department of Radiology, University of Michigan, Ann Arbor, Michigan, USA.
  • Morris K. Udall Center of Excellence for Parkinson's Disease Research, University of Michigan, Ann Arbor, Michigan, USA.
  • Department of Radiology, University of Michigan, Ann Arbor, Michigan, USA.
  • Parkinson's Foundation Research Center of Excellence, University of Michigan, Ann Arbor, Michigan, USA.
  • Neurology Service and GRECC, Veterans Administration Ann Arbor Healthcare System, Ann Arbor, Michigan, USA.

ORCID-Profile: Prabesh Kanel, Stiven Roytman, Roger L Albin, Nicolaas I Bohnen

Förderung

  • Michael J. Fox Foundation for Parkinson's Research
  • NINDS NIH HHS
  • NIH HHS
  • RRD VA
  • NIA NIH HHS
  • National Institutes of Health
  • U.S. Department of Veterans Affairs

Zitieren

APA

Chou, K. L., Kanel, P., van Emde Boas, M., Roytman, S., Carli, G., Albin, R. L., & Bohnen, N. I. (2025). Cholinergic System Changes in Dopa‐Unresponsive Freezing of Gait in Parkinson's Disease. Movement Disorders. https://doi.org/10.1002/mds.30196

Vancouver

Chou KL, Kanel P, van Emde Boas M, Roytman S, Carli G, Albin RL, et al. Cholinergic System Changes in Dopa‐Unresponsive Freezing of Gait in Parkinson's Disease. Movement Disorders. 2025. doi:10.1002/mds.30196

BibTeX
@article{Chou2025,
  author = {Chou, Kelvin L and Kanel, Prabesh and van Emde Boas, Miriam and Roytman, Stiven and Carli, Giulia and Albin, Roger L and Bohnen, Nicolaas I},
  title = {Cholinergic System Changes in Dopa‐Unresponsive Freezing of Gait in Parkinson's Disease},
  journal = {Movement Disorders},
  year = {2025},
  doi = {10.1002/mds.30196}
}
Kostenlos starten →